Aebersold Sarah, Chief Human Resources Officer at BioLife Solutions (BLFS), has demonstrated a consistent pattern of selling company stock over the past two years, with no recorded purchases. Since April 2024, she has executed 20 sales totaling $861,343, with the largest transactions concentrated in early 2025. Notably, three high-value sales occurred in March 2025, including a $192,914 disposition on March 12, followed by $140,575 on March 14 and $68,561 on March 17. These transactions accounted for nearly half of her total sell volume. More recently, her activity has shifted toward smaller, more frequent sales, such as a $17,801 transaction on March 19, 2026, and a $4,542 sale on March 3, 2026.
The filings show no open-market purchases during this period, though she received awards (coded "A") in March 2025 and February 2026 with no reported value. Her selling has been methodical, with transactions occurring monthly or bimonthly at varying sizes, ranging from $1,264 in May 2024 to the six-figure dispositions in early 2025. The absence of buying activity and the sustained selling pattern suggest a focus on reducing her BLFS position rather than accumulating shares. The transactions appear to follow no strict schedule, though the clustering of sales in early 2025 and early 2026 may reflect post-award dispositions or personal liquidity events.
AI-assisted summary